Official
Do you want to contribute to the development of R&D&I in our country? With this PhD you will be prepared to work as a researcher at the highest level.
Scientific advances are helping to improve society's quality of life, with a notable increase in life expectancy. Thanks to research focused on anticipating the manifestation of ailments, there is hope that, in the future, the adverse effects of diseases can be controlled.
Tackling the "physical deterioration caused by disease" is one of the great battles being waged in research in fields such as regenerative biology, which is looking further into the search for alternatives that involve "improving the patient's health by using their own cells". This opens the door to personalised medicine, where new therapies can be tested and the most appropriate one found for each patient. This is an aspect in which companies working in the search for drugs are very interested
Aware of this, the Alfonso X el Sabio University (UAX) has launched the Regenerative Biology and New Therapies Doctoral Programme, which has the collaboration of the Instituto de Salud Carlos III and the Hospital Universitario Clínico San Carlos. An international and cross-disciplinary programme aimed at graduates in biomedical or experimental sciences, including graduates in Medicine, Biology, Biochemistry, Biotechnology, Veterinary Medicine or Pharmacy.
This doctoral programme offers students training that will enable them to join the world of research, a clinic, pharmaceutical companies or the world of industrial applications. The programme, committed to training high quality researchers and with first class research teams, is intense, exhaustive and personalised.
A forward-looking educational experience that is not limited to the classroom. The PhD programme includes stays of "at least three months in a laboratory outside the UAX, in Spain or abroad".
This programme is presented with two lines of research:
Programme coordinator:
Academic Committee:
Other professionals who are not associated with the programme's lines of research, but who have a relevant qualification in the corresponding field of knowledge, may collaborate in these activities.
The training activities scheduled for this doctoral programme are:
The PhD programme is based on a theoretical-practical methodology to offer you an enriching training in the field of Health Sciences.
The strategic alliance between UAX, the Instituto de Salud Carlos III, the Hospital Clínico San Carlos and the CSIC has made it possible to offer a top-level research team that guarantees quality training.
In addition, you will be able to enrich your training with stays in foreign centres of recognised prestige, which will give your studies an international dimension, such as:
The PhD Programme in Regenerative Biology and New Therapies has the following material resources and infrastructures:
In addition, doctoral students have access to the laboratories and resources available in the institutions and centres with which the appropriate collaboration agreements have been established: CSIC, Hospital Clínico San Carlos and, specifically, the Hospital Clínico San Carlos.
Within the PhD programme in Regenerative Biology and New Therapies, and its framework of strategic alliances to offer an enriching education focused on training professionals who respond to the demands of society, the UAX has signed a strategic agreement with ESAME Pharmaceutical Business School, with the aim of offering the option of developing an INDUSTRIAL DOCTORATE programme.
WHAT IS THE INDUSTRIAL DOCTORATE?
This type of doctorate is carried out within companies, both in the private and public sector, in which the doctoral thesis will be developed within a company project focused on research and innovation in new therapies, for three years in a business environment, bringing university research closer to and adapting it to the needs of the company and responding to the challenges that society demands.
Through this option, the UAX wishes to professionally train those future PhDs interested in a professional future in the Pharmaceutical, Biotechnological and/or Healthcare Industry, turning them into researchers with an essential background to enhance their incorporation into the pharmaceutical industry.
WHAT ADVANTAGES DOES IT OFFER THE STUDENT?
You will have the opportunity to join a Research, Development and Innovation project with a company in the Pharma sector, which will generate high added value to your CV.
You will have the support and constant supervision of professionals who carry out research activity in the business environment, in addition to the university itself. This will facilitate your progress.
You will be able to work in the facilities of companies in the sector, immersing yourself in the R+D+i activity of a company in the Pharma sector.
A great opportunity of this doctorate is to receive complementary training with the aim of acquiring skills and knowledge that are of great interest and useful to companies in the Pharma sector.
Finally, your training in this industrial doctorate will enhance your profile as a high-value professional for companies in the Pharma, Biotech or Healthcare sector, due to the business training in the area of R&D&I received.
ARE YOU INTERESTED?
If you would like more information, such as the requirements for your doctoral thesis to be awarded the Industrial Doctorate mention or the admission requirements, please contact Iván Herrera at the following e-mail address: iherrpec@uax.es
Line 1: Research in Regenerative Biology and Intracellular Signalling
Dr. José María Rojas: Head of the Cell and Developmental Biology Area at the Carlos III Institute of Health (ISCIII) and Coordinator of Biology and Biochemistry II within the Degree in Medicine at the Alfonso X el Sabio University.
Dr. Mª Rosario Baquero Artigao: Dean of the Faculty of Health Sciences at UAX, PhD in Pharmacy from the UCM. Co-director of the Doctorate Programme "Regenerative Biology and New Therapies". 25 years of research experience in Microbiology and Molecular Biology. 3 six-year research periods and more than 10 doctoral theses supervised.
Dr. Juan José Peña Deudero: Head of Studies of the Degree in Biotechnology. PhD in Biochemistry and Molecular Biology from the Complutense University of Madrid. Research accredited by the CNEAI, research activities at the Fundación Jiménez Díaz, as well as at Baylor College of Medicine, Houston, USA.
Dr. Daniel Peña Jiménez: PhD in Molecular Biosciences from the Universidad Autónoma de Madrid in 2019. He completed his doctoral thesis at the Spanish National Cancer Research Centre (CNIO). 10 years of research experience and 7 years of teaching experience. 5 publications in prestigious journals.
Dr. Alba del Río Lorenzo: PhD in Biomedical Research from the University of Valladolid in 2020. Predoctoral stay at Helmholtz Zentrum München in Germany. Almost ten years of research experience and two years of teaching experience in the area of medicine at the Alfonso X el Sabio University.
Dr. Mónica Yunta González: PhD in Biology in the Immunology Programme at the UCM (2002). Master's degree in Neuroscience from the Universidad Pablo de Olavide (2008). 21 publications in journals. Participation in 16 funded projects, in three of them as principal investigator. 4 years postdoctoral stay in Pennsylvania.
Dr. Jesús Romero Pozuelo: PhD in Biology. Research professor at the UIB-UAX. Research experience in different well-known international centres. Several publications in high impact scientific journals.
Line 2: Research in New Therapies and Cell Regulation
Dr. Javier García Castro: Doctor in Biology. Coordinator of the doctoral programme in veterinary health. More than 80 scientific publications.
Dr. Fernando Ánibal Vázquez Fernández: PhD in veterinary medicine from the University of Murcia. Member of research groups. Director of the Veterinary Clinical Hospital (HCV-UAX). More than 20 scientific publications.
Dr. Ana Judith Perisé Barrios: PhD in Biochemistry, Molecular Biology, Biomedicine and Biotechnology from the Autonomous University of Madrid in 2013. 11 scientific publications in prestigious journals.
Dr. Victoria Seijas Martínez-Echevarría: PhD in Pharmacy from the Complutense University of Madrid. Specialist in Clinical Biochemistry with more than 15 publications in national and international journals and more than 50 contributions to conferences.
Dr. Rodolfo Oliveira Leal: PhD from the University of Lisbon. Specialist in small animal medicine with more than 15 indexed publications and numerous contributions and presentations at conferences.
Pathway and entry requirements:
In addition, students must have a B2 level of English, be able to handle bibliographic resources and basic information and communication technology (ICT) tools efficiently, and have the ability to synthesise, be critical, creative, draw conclusions and analyse data.
The admission process to the Doctoral Programme may conclude with the obligation for the student to complete and pass specific Complementary Training Courses.
Admission criteria and tests:
Applicants must apply for admission to the programme's academic committee. This committee will determine, depending on the admission profile, the direct admission, the need to take complementary training for admission or non-admission.
Admission criteria:
Training complements
The academic committee, in view of the admission application, will determine whether the candidate must take complementary courses. These are made up of 2 subjects:
In each case, each student will be informed, in the response to their application for admission to this doctoral programme, of the need to pass both subjects, or one of the two, and that their definitive admission to the programme will be conditional on passing the complementary courses.
Number of new places offered:
10
We need to know a little about you so that we can give you a personalised service.
All fields are required
A unique centre in Spain to complete your training in the most innovative, well-rounded way. Find out more
First healthcare facility created by UAX to provide you with the most comprehensive training focused on real-world practice. Find out more
Using the most innovative medical resources, it aims to offer the best diagnosis and treatment of real patients. Find out more
The Degree Monitoring and Improvement Committee is made up of the programme management, the dean of the centre to which the degree is attached, a representative of the programme directors, a representative of the doctoral students, the centre's quality coordinator and a representative of the Vice-Rector's Office for Studies and Quality.
In addition, guest members may be invited to deal with specific issues that need to be monitored.
The Programme Quality Committee is made up of the following members:
- Establish the employability part of the PhD through ASeBIO and Career Services.
- To give greater visibility to the doctoral programme
- Disseminate more clearly the training activities to be carried out by doctoral students.
- Seek collaboration with companies to carry out the doctorate.
We listen to the real demand of our students and employees, because we believe in continuous improvement of results. Therefore, we always want to hear everything you want to tell us.
If you already belong to the UAX, through the virtual campus in the section Customer service: complaints, suggestions and congratulations, entering your username and password.
Telephone: 91 810 9400
E-mail: paramejorar@uax.es
Opening hours: Monday to Friday from 9:00 am to 6:00 pm
+34 91 910 01 70
+34 91 910 01 70
